Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings: Two Randomized Clinical Trials.

ABSTRACT:

Importance

Expansion of opioid use disorder treatment is needed, particularly in rural communities.

Objective

To evaluate technology-assisted buprenorphine (TAB) efficacy (1) over a longer period than previously examined, (2) with the addition of overdose education, and (3) among individuals residing in rural communities.

Design, setting, and participants

Two parallel, 24-week randomized clinical trials were conducted at the University of Vermont between February 1, 2018, and June 30, 2022. Participants were adults with untreated opioid use disorder from nonrural (trial 1) or rural (trial 2) communities. These trials are part of a programmatic effort to develop TAB protocols to improve treatment availability in underserved areas.

Interventions

Within each trial

SUBMITTER: Sigmon SC 

PROVIDER: S-EPMC10534272 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature